Expediting clinical trials in a pandemic
- 10 November 2009
- Vol. 339 (nov10 1) , b4652
- https://doi.org/10.1136/bmj.b4652
Abstract
In response to the urgent need for paediatric data comparing the two new variant A/H1N1 vaccines in the UK before the onset of a second wave of flu,1 and a call for proposals related to new variant A/H1N1 by the National Institute for Health Research (NIHR),2 we designed a clinical trial of immunogenicity and tolerability in children aged 6 months-12 years. We submitted a collaborative funding application to NIHR on 24 July 2009, receiving an award letter …Keywords
This publication has 0 references indexed in Scilit: